Objective: To evaluate the complications, survival and oncological outcome of patients ≥75 years of age after radical cystectomy for muscle-invasive bladder cancer. Patients and Methods: Between April 1993 and August 2010, 765 patients with muscle-invasive bladder cancer underwent radical cystectomy at one high-volume center. Of these, 70 patients were ≥75 years of age. All 70 patients had at least one severe systemic comorbidity with an American Society of Anesthesiologists score of 3. Primary endpoints of this retrospective study were overall and recurrence-free survival with a mean follow-up of 22 months (1-159). Perioperative parameters such as need for blood transfusions, hospital stay, mortality, short- and long-term complications were also assessed. Complications were graded according to the Clavien-Dindo classification. Results: Perioperative complications occurred in 23/70 patients (33%) with a 30-day mortality rate of 1.4%. 16/70 patients (23%) developed late complications requiring hospitalization. Within 30 days of surgery, according to the Clavien-Dindo grading, 27% had no complications, 3% grade 1, 49% grade 2, 14% grade 3, 6% grade 4 and 1.4% grade 5 complications. Within 31-90 days after surgery, 76% had grade 1 complications, 3% grade 2, 6% grade 3, 9% grade 4 and 6% grade 4 complications. The calculated 5- and 8-year overall survival rates were 30 and 25%, respectively, with a recurrence-free survival rate of 52% at 5 and 42% at 8 years. Conclusions: Radical cystectomy is an appropriate and effective treatment for comorbid elderly patients. The oncological long-term outcome is the same as in younger patients while overall survival is comparatively lower. Mortality and complication-related morbidity are comparable to those in younger patients with modern perioperative management.

Journal Section:
Editor's choice
Keywords:
Bladder cancer, Muscle-invasive bladder cancer, Radical cystectomy, Complications, Age, Survival, Comorbidity , Ileus
1.
Diczfalusy E: The demographic revolution and our common future. Maturitas 2001;38:5-15.
[PubMed]
https://doi.org/10.1016%2FS0378-5122%2800%2900187-0
2.
Madersbacher S, Bauer W, Willinger M, Wehrberger C, Berger I, Brössner C: Radical cystectomy for bladder cancer in the 70+ population: a nation-wide registry analysis of 845 patients. Urol Int 2010;85:287-290.
[PubMed]
https://doi.org/10.1159%2F000316100
3.
Charlson ME, Pompei P, Ales KL, Mackenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-383.
[PubMed]
https://doi.org/10.1016%2F0021-9681%2887%2990171-8
4.
Mullins JK, Guzzo TJ, Ball MW, Pierorazio PM, Eifler J, Jarrett TW, Schoenberg MP, Bivalacqua TJ: Ureteral stents placed at the time of urinary diversion decreases postoperative morbidity. Urol Int 2012;88:66-70.
[PubMed]
https://doi.org/10.1159%2F000335212
5.
Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19:666-675.
[PubMed]
6.
Chang SS, Cookson MS, Baumgartner RG, Wells N, Smith JA: Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol 2002;167:2012-2016.
[PubMed]
https://doi.org/10.1016%2FS0022-5347%2805%2965074-4
7.
Mezuk B: Epidemiology of diabetes and cardiovascular disease. The emergence of health disparities over the life span. Annu Rev Gerontol Geriatr 2009;29:77-97.
https://doi.org/10.1891%2F0198-8794.29.77
8.
Fuller-Iglesias H, Smith J, Antonucci TC: Theories of aging from a life-course and life-span perspective. Annu Rev Gerontol Geriatr 2009;29:3-25.
https://doi.org/10.1891%2F0198-8794.29.3
9.
Crimmins EM: Trends in the health of the elderly. Annu Rev Public Health 2004;25:79-98.
[PubMed]
https://doi.org/10.1146%2Fannurev.publhealth.25.102802.124401
10.
Froehner M, Brausi MA, Herr HW, Muto G, Studer UE: Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 2009;56:443-454.
[PubMed]
https://doi.org/10.1016%2Fj.eururo.2009.05.008
11.
May M, Fuhrer S, Braun KP, Brookmann-Amissah S, Richter W, Hoschke B, Vogler H, Siegsmund M: Results from three municipal hospitals regarding radical cystectomy on elderly patients. Int Braz J Urol 2007;33:764-776.
[PubMed]
https://doi.org/10.1590%2FS1677-55382007000600004
12.
Yamanaka K, Miyake H, Hara I, Inoue TA, Fujisawa M: Significance of radical cystectomy for bladder cancer in patients over 80 years old. Int Urol Nephrol 2007;39:209-214.
[PubMed]
https://doi.org/10.1007%2Fs11255-006-9122-5
13.
Gamé X, Soulié M, Seguin P, Vazzoler N, Tollon C, Pontonnier F, Plante P: Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality. Eur Urol 2001;39:525-529.
[PubMed]
https://doi.org/10.1159%2F000052498
14.
Sogni F, Brausi M, Frea B, Martinengo C, Faggiano F, Tizzani A, Gontero P: Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Urology 2008;71:919-923.
[PubMed]
https://doi.org/10.1016%2Fj.urology.2007.11.125
15.
Soulié M, Straub M, Gamé X, Seguin P, De Petriconi R, Plante P: A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer. J Urol 2002;167:1325-1328.
[PubMed]
https://doi.org/10.1016%2FS0022-5347%2805%2965292-5
16.
Zebic N, Weinknecht S, Kroepfl D: Radical cystectomy in patients aged ≥75 years: an updated review of patients treated with curative and palliative intent. BJU Int 2005;95:1211-1214.
[PubMed]
https://doi.org/10.1111%2Fj.1464-410X.2005.05507.x
17.
Chang SS, Alberts G, Cookson MS, Smith JA: Radical cystectomy is safe in elderly patients at high risk. J Urol 2001;166:938-941.
[PubMed]
https://doi.org/10.1016%2FS0022-5347%2805%2965868-5
18.
Deliveliotis C, Papatsoris A, Chrisofos M, Dellis A, Liakouras C, Skolariskos A: Urinary diversion in high-risk elderly patients: modified cutaneous ureterostomy or ileal conduit? Urology 2005;66:299-304.
[PubMed]
https://doi.org/10.1016%2Fj.urology.2005.03.031
19.
Liquori G, Trombetta C, Pomara G, Amodeo A, Bucci S, Garaffa G: Major invasive surgery for urological cancer in octogenarians with comorbid medical conditions. Eur Urol 2007;51:1600-1605.
[PubMed]
https://doi.org/10.1016%2Fj.eururo.2006.07.046
20.
Donat SM, Siegrist T, Cronin A, Savage C, Milowsky MI, Herr HW: Radical cystectomy in octogenarians - does morbidity outweigh the potential survival benefits? J Urol 2010;183:2171-2177.
[PubMed]
https://doi.org/10.1016%2Fj.juro.2010.02.015
21.
Serra CA, Narbon SE, Briones RJ, Ramon-Borja CJ, Juan II, Torrent RJ: Is radical cystectomy justified in patients over 75 years old? (in Spanish). Actas Urol Esp 2008;32:288-296.
[PubMed]
22.
Lee KL, Freiha F, Presti JC, Gill HS: Gender differences in radical cystectomy: complications and blood loss. Urology 2004;63:1095-1099.
[PubMed]
https://doi.org/10.1016%2Fj.urology.2004.01.029
23.
de Vries RR, Kauer P, van Tinteren H, van der Poel HG, Bex A, Meinhardt W, van Haarst EP, Horenblas S: Short-term outcome after cystectomy: comparison of two different perioperative protocols. Urol Int 2012; 88:383-389.
[PubMed]
https://doi.org/10.1159%2F000336155
24.
Boström PJ, Kössi J, Laato M, Nurmi M: Risk factors for mortality and morbidity related to radical cystectomy. BJU Int 2008;103:191-196.
[PubMed]
https://doi.org/10.1111%2Fj.1464-410X.2008.07889.x
25.
Hautmann RE, Petriconi RC, Volkmer BG: Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol 2010;184:990-994.
[PubMed]
https://doi.org/10.1016%2Fj.juro.2010.05.037
26.
Hollenbeck BK, Miller DC, Taub D, Dunn RL, Khuri SF, Henderson WG, Montie JE, Underwood W, Weis JT: Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol 2005;174:1231-1237.
[PubMed]
https://doi.org/10.1097%2F01.ju.0000173923.35338.99
27.
March VJA, Martinez JM, Pastor HF, Günthner SFJ, Rodriguez NR, Chuan NP: Radical cystectomy as a muscle-invasive bladder cancer treatment in elderly patients (in Spanish). Actas Urol Esp 2008;32:696-704.
[PubMed]
28.
Wolters U, Wolf T, Stützer H, Schröder T: ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 1996;77:217-222.
[PubMed]
https://doi.org/10.1093%2Fbja%2F77.2.217
29.
Hofner T, Haferkamp A, Knapp L, Pahernik S, Hadaschik B, Djakovic N, Wagener N, Hohenfellner M: Preoperative hydronephrosis predicts advanced bladder cancer but is not an independent factor for cancer-specific survival after radical cystectomy. Urol Int 2011;86:25-30.
[PubMed]
https://doi.org/10.1159%2F000321008
30.
Mendiola FP, Zorn KC, Gofrit ON, Mikhail AA, Orvieto MA, Msezane LP, Steinberg GD: Cystectomy in the ninth decade: operative results and long-term survival outcomes. Can J Urol 2007;14:3628-3634.
[PubMed]
31.
Morgan TM, Keegan KA, Barocas DA, Ruhotina N, Philips SE, Chang SS, Penson DF, Clark PE, Smith JA, Cookson MS: Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol 2011;186:829-834.
[PubMed]
https://doi.org/10.1016%2Fj.juro.2011.04.089
32.
Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, Skinner DG: Radical cystectomy in the elderly: comparison of clinical outcomes between younger and older patients. Cancer 2005;104:36-43.
[PubMed]
https://doi.org/10.1002%2Fcncr.21126
33.
Lawrentschuk N, Colombo R, Hakenberg OW, Lerner SP, Mansson W, Sagalowsky A, Wirth MP: Prevention and management of complications following radical cystectomy for bladder cancer. Eur Urol 2010;57:983-1001.
[PubMed]
https://doi.org/10.1016%2Fj.eururo.2010.02.024
34.
Fairey AS, Jacobsen NEB, Chetner MP, Mador DR, Metcalfe JB, Moore RB, Rourke KF, Todd GT, Venner PM, Voaklander DC, Estey EP: Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta urology institute radical cystectomy database. J Urol 2009;182:85-93.
[PubMed]
https://doi.org/10.1016%2Fj.juro.2008.11.111
35.
Nuhn P, Bastian PJ, Novara G, Svatek RS, Karakiewicz PI, Skinner E, Fradet Y, Izawa JI, Kassouf W, Montorsi F, Müller SC, Fritsche HM, Sonpavde G, Tilki D, Isbarn H, Ficarra V, Dinney CP, Shariat SF: Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery. Urol Int 2011;87:42-48.
[PubMed]
https://doi.org/10.1159%2F000325463
© 2013 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2013
You do not currently have access to this content.